Eureka Therapeutics, Inc.
Records under this name other than the patents Eureka Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Back to Eureka Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,074,000 | T Cell Receptor-Like Antibodies Specific for a Wti Peptide Presented by HLA-A2 No holder on record In force · High confidence | In force | High confidence | |
| US 10,239,952 | ANTI-WT1/HLA Bi-Specific Antibody Formerly held In force · High confidence | In force | High confidence | |
| US 10,562,972 | Antibodies Targeting B-Cell Maturation Antigen and Methods of Use Held by another company In force · Low confidence | In force | Low confidence | |
| US 10,590,196 | Antibodies Targeting G-Protein Coupled Receptor and Methods of Use Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 10,633,426 | Chimeric Antigen Receptors Targeting G-Protein Coupled Receptor and Uses Thereof Held by another company In force · High confidence | In force | High confidence | |
| US 10,821,135 | Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen and Uses Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,918,665 | Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen and Uses Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,000,549 | Methods of Using Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen and Uses Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,168,150 | T Cell Receptor-Like Antibody Agents Specific for Ebv Latent Membrane Protein 2A Peptide Presented by Human Hla Held by another company In force · High confidence | In force | High confidence | |
| US 11,136,392 | Novel PD-1 Immune Modulating Agents Formerly held In force · High confidence | In force | High confidence |